Long intergenic non-protein coding RNA 2596 (LINC02596)

Long intergenic non-protein coding RNA 2596 (LINC02596) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed, non-coding RNA molecules longer than 200 nucleotides that do not overlap annotated coding genes[1][3][5]. LincRNAs are implicated in various biological processes, primarily as regulators of gene expression, including chromatin remodeling, transcription regulation, RNA stabilization, and enhancer-associated activity[5][7]. These molecules generally exhibit tissue specificity and can regulate neighboring genes through sequence-dependent and sequence-independent mechanisms, but for LINC02596 specifically, little functional or disease-related information is currently available in public biomedical databases[1][3][5]. No evidence was found indicating LINC02596 is a receptor, enzyme, transporter, drug target, or established biomarker, nor is there data supporting direct involvement in human disease. As such, it should be classified under non-coding RNAs (lincRNAs) rather than therapeutic targets for current biomedical or pharmacological purposes[1][3][5][7].

Other names

LINC02596LOC105376834